The short answer
Part A covers inpatient care, Part B covers outpatient and doctor care, Part C bundles both through a private plan, and Part D covers drugs. For 2026 Medicare.gov lists a $1,736 Part A deductible per benefit period, a $202.90 Part B premium, a $283 Part B deductible, and a $2,100 Part D out-of-pocket ceiling.
Where chemotherapy is given decides which part pays: Part A as a hospital inpatient, Part B as a hospital outpatient, in a doctor's office, or in a freestanding clinic.
For 2026, Medicare.gov lists a Part A deductible of $1,736 per benefit period — and says there is no limit on how many benefit periods a year can contain.
The 2026 standard Part B premium is $202.90 a month, with a $283 annual deductible and a usual 20% coinsurance after that.
Part D reaches catastrophic coverage once out-of-pocket spending on covered drugs hits $2,100 in 2026, after which covered Part D drugs cost nothing for the rest of the year.
Choose how you want to understand this
The full explanation.
Four parts, and what each one pays for
Medicare.gov describes the parts this way.
- Part A, hospital insurance. Inpatient hospital care, skilled nursing facility care, hospice care, and home health care.
- Part B, medical insurance. Doctors and other providers, outpatient care, home health care, durable medical equipment such as wheelchairs and walkers, and many preventive services.
- Part D, drug coverage. Prescription drugs, including many recommended shots and vaccines. It is run by private insurers under Medicare rules.
- Part C, Medicare Advantage. A private plan approved by Medicare that bundles Part A, Part B, and usually Part D.
Medigap sits outside that list. Medicare.gov calls it extra insurance bought from a private company to help pay a person's share of costs in Original Medicare. Policies are standardized and, in most states, named by letters such as Plan G or Plan K. The benefits in each lettered plan are identical no matter who sells it.
Where chemotherapy lands, and why it matters
Medicare.gov splits cancer treatment across two parts based on where it is given.
Part A covers chemotherapy for a hospital inpatient. Part B covers chemotherapy given to a hospital outpatient, in a doctor's office, or in a freestanding clinic.
The cost rule follows. After the Part B deductible, the usual share is 20% of the Medicare-approved amount for chemotherapy in a doctor's office, freestanding clinic, or hospital outpatient setting. In a hospital outpatient setting, Medicare.gov says the copayment will not exceed the inpatient hospital deductible amount.
Clinical trials get their own line. Medicare.gov says Part A and Part B cover some costs of certain clinical research studies, such as office visits and tests, with the usual 20% share after the Part B deductible.
The 2026 numbers for Part A
Medicare.gov publishes these figures for 2026.
Most people pay no Part A premium, because they or a spouse paid Medicare taxes for generally at least 10 years. For those who do not qualify, the premium is either $311 or $565 a month.
The Part A deductible is $1,736 for each inpatient hospital benefit period. Medicare.gov is explicit that there is no limit on the number of benefit periods in a year, so that deductible can be owed more than once in twelve months.
Inpatient days are priced in tiers. Days 1 through 60 cost $0 after the deductible. Days 61 through 90 cost $434 each. Days 91 through 150 cost $868 each, drawing on 60 lifetime reserve days. After day 150, the patient pays all costs.
Skilled nursing works the same way. Days 1 through 20 cost $0. Days 21 through 100 cost $217 each. From day 101, the patient pays all costs.
Hospice care is $0 for covered services, with a copayment of up to $5 for each prescription drug for pain relief and symptom control at home, and 5% of the approved amount for inpatient respite care.
The 2026 numbers for Part B
The standard Part B premium is $202.90 a month in 2026, higher for higher incomes. It is owed every month, whether or not any services are used.
The Part B deductible is $283, paid once each year. After that, the usual share is 20% of the cost for each covered service, provided the doctor accepts the Medicare-approved amount as full payment, which Medicare.gov calls accepting assignment.
Two lines are worth knowing during cancer care. Covered clinical laboratory services cost $0. And in a hospital outpatient clinic, there is an added copayment to the hospital, which in most cases will not be more than the Part A hospital deductible. Medicare.gov notes plainly that the same service can cost more in a hospital outpatient department than in a doctor's office.
What changed in Part D
Part D now has three stages, and the third one is new enough that many summaries have not caught up.
In 2026, no Medicare drug plan may have a deductible above $615, and some have none. After the deductible, the initial coverage stage charges 25% coinsurance for generic and brand-name drugs. That continues until out-of-pocket spending on covered Part D drugs reaches $2,100 in 2026, including certain payments made on a person's behalf through the Extra Help program.
Then catastrophic coverage starts automatically. Medicare.gov states that after that point there is no out-of-pocket cost for covered Part D drugs for the rest of the calendar year.
For anyone taking an expensive oral cancer drug, that $2,100 figure is the number that defines the worst case for the year, as long as the drug is on the plan's list.
The gap Original Medicare leaves
Medicare.gov states it directly: there is no yearly limit on out-of-pocket costs unless a person has supplemental coverage such as Medigap, or joins a Medicare Advantage plan.
That is the structural difference between the two paths. Original Medicare can be used with any doctor or hospital that takes Medicare, anywhere in the United States, including all 50 states, the District of Columbia, Puerto Rico, the US Virgin Islands, Guam, the Northern Mariana Islands, and American Samoa. Medicare Advantage plans usually require network doctors and prior approval for certain drugs or services, but they carry an out-of-pocket limit, after which the plan pays 100% of covered services for the rest of the calendar year.
Medicare Advantage enrollees still pay the Part B premium. Medicare.gov is explicit that a person must have Part B and keep paying that premium to stay in the plan. The same rule applies to keeping a Medigap policy.
Enrollment timing, and the penalties
The Initial Enrollment Period lasts 7 months. It starts 3 months before the month someone turns 65 and ends 3 months after that month.
Missing it has consequences. Medicare.gov says a late enrollment penalty for Part B is paid monthly for as long as Part B is held, and grows the longer someone waits. The General Enrollment Period runs January 1 through March 31 each year, with coverage starting the month after signup.
Part D has its own trap. The penalty applies to anyone who goes 63 days or more without creditable drug coverage, meaning coverage similar in value to Part D. Medicare.gov suggests joining a low-premium drug plan even for people taking few drugs, precisely to avoid it.
People with limited income and resources may qualify for state help with premiums and other costs, and for Extra Help with drug costs. Medicare.gov says qualifying for Extra Help also removes the Part D late enrollment penalty.
Where to read next
Cancer-specific coverage questions are handled in Medicare and cancer. The difference between the two programs is drawn in Medicare vs. Medicaid. Having both at once is covered in dual eligibility.
Sources
Words to know
Tap any term to see what it means.

Common questions
What is Part A, and what does it cost in 2026?
Part A is hospital insurance, covering inpatient hospital care, skilled nursing facility care, hospice, and home health care. Most people pay no premium because they or a spouse paid Medicare taxes for generally at least 10 years; those who do not qualify pay $311 or $565 a month. The 2026 deductible is $1,736 per inpatient benefit period, and Medicare.gov notes there is no limit on the number of benefit periods in a year.
What is Part B, and what does it cost in 2026?
Part B is medical insurance, covering doctors and other providers, outpatient care, home health care, durable medical equipment, and many preventive services. The 2026 standard premium is $202.90 a month, higher at higher incomes. The annual deductible is $283, after which the usual share is 20% of the Medicare-approved amount when the provider accepts assignment. Covered clinical laboratory services cost $0.
Which part pays for chemotherapy?
Medicare.gov splits it by setting. Part A covers chemotherapy for a hospital inpatient. Part B covers it for a hospital outpatient, in a doctor's office, or in a freestanding clinic. After the Part B deductible, the typical share is 20% of the Medicare-approved amount, and in a hospital outpatient setting the copayment will not be more than the inpatient hospital deductible amount.
How does Part D work now?
In three stages. In 2026 no Medicare drug plan may have a deductible above $615, and some have none. In the initial coverage stage the share is 25% coinsurance for generic and brand-name drugs. Once out-of-pocket spending on covered Part D drugs reaches $2,100 in 2026, catastrophic coverage begins automatically and covered Part D drugs cost nothing for the rest of the calendar year.
Do Parts A and B cover everything?
No. Medicare.gov states there is no yearly limit on out-of-pocket costs unless a person has supplemental coverage such as Medigap or joins a Medicare Advantage plan. Medicare Advantage plans do carry an out-of-pocket limit, after which the plan pays 100% of covered health services for the rest of the calendar year, but they usually require network providers and prior approval for certain drugs or services.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Your care team's answer depends on your treatment — ask them directly.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Knowledge Check
0 of 4 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
Where to get help with this, by name
A hospital social worker or financial navigator is the best first call if you have one. If you do not, these organisations help at no cost to you.
- Patient Advocate Foundation — (800) 532-5274. Case managers take on insurance appeals, denials and medical debt with you. Free.
- TotalAssist (Patient Advocate Foundation's copay programme, merged with the PAN Foundation in 2026) — 866-512-3861. Help with medication copays, coinsurance and deductibles, insurance premiums, and office-visit and administration charges on the day of treatment, across nearly 150 conditions.
- CancerCare — 800-813-HOPE (4673). Oncology social workers, free counselling and support groups. Limited financial help with transport, home care, child care and lodging for people in active treatment who meet their income guidelines — funding is first-come, first-served, so call to ask what is open.
- Triage Cancer — 424-258-4628. Free legal and financial navigation: insurance, employment rights, disability.
- Blood Cancer United (formerly the Leukemia & Lymphoma Society) — (800) 955-4572. Information Specialists answer questions on treatment, insurance and financial problems.
- HealthCare.gov — 1-800-318-2596. For questions about the external review process — the independent review your insurer is required by law to accept.
Your state Department of Insurance regulates insurers and takes consumer complaints. On Medicare, your State Health Insurance Assistance Program (SHIP) gives free one-to-one counselling. If a specific drug is the problem, ask the manufacturer about its patient assistance programme.
Phone numbers checked 31 July 2026. Programmes and eligibility change — if a number has moved, please tell us.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Last updated: 2026-08-06Next planned review: 2027-01-07
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share
